Mounjaro 7.5mg Shortage Status October 2026
GLP-1 medication shortages continue to frustrate users across the country. We’re sharing up-to-date tracking on availability and alternatives.
Stock Status
Currently, the shortage situation for these drugs is highly variable by:
- Specific medication and strength: Initial titration doses are often easier to find than higher strengths
- State and region: Allocation send more stock to high-volume markets while rural areas get less
- Where you fill: Non-chain pharmacies sometimes have products not in chain supply
Dose-Specific Tracking
Initial Titration Strengths
Starter doses are generally in better supply because:
- Fewer patients remains on starting strength long-term
- Pharma companies focus production on initial supply to ensure initiation of therapy
Target Strengths
Target dosing experience worse shortages because:
- Most patients graduate to these strengths and stay there
- Manufacturing can’t keep up the cumulative patient load
What to Do
Right Now
- Phone before visiting — avoid going to the store before verifying availability
- Cast a wide net — call at least 5 stores not just chains
- Get on a notification list — some locations will call when stock arrives
Extended Supply Issues
- Contact your doctor about dose adjustments — your prescriber could authorize dose splitting
- Consider compounded options — when your medication is officially in shortage, custom formulations can be prescribed
- Check manufacturer assistance — both Novo Nordisk and Eli Lilly have resources to locate medication
Monitoring Resources
Monitor these channels to track availability:
- The official FDA list — the most reliable data
- Novo Nordisk and Eli Lilly — production news published by the source
- Your pharmacy app — may display whether it’s in stock
- Patient communities — other patients report live stock findings
We refresh this tracker as conditions change.